FDA Inspection
University Of Texas MD Anderson Cancer Center: PETUniversity Of Texas MD Anderson Cancer Center: PET – FDA Inspection, Mar 20, 2018
Record Details
This FDA Inspection record concerns University Of Texas MD Anderson Cancer Center: PET, with an inspection on March 20, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- March 20, 2018
- Product Type
- Drugs
View Company Profile
ID · f7ee65f0-9bf5-4b3e-af82-ca180296c496
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1045262
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
FDA Citations
3- 21 CFR 314.81(b)(2)Timely submission
- 21 CFR 314.80(c)(2)Late submission of quarterly safety reports
- 21 CFR 314.80(b)Failure to develop written procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of University Of Texas MD Anderson Cancer Center: PET
3| Date | Classification | Office | Project area |
|---|---|---|---|
| February 24, 2026 | Not classified | Dallas District Office | Drug Quality Assurance |
| July 25, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 16, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for University Of Texas MD Anderson Cancer Center: PET
- FDA Inspection 1301436 - 2026-02-24
- FDA Inspection 981292 - 2016-07-25
- FDA Inspection 850187 - 2013-09-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.